national
ETV Bharat / Covaxin
No link between Covid vaccines used in India and heart attack risk: Study
Sep 4, 2023
ETV Bharat English Team
SII's Covovax can now be used as heterologous booster, DCGI approves market authorisation
Jan 17, 2023
Bharat Biotech's partner says Covaxin shows positive results in Phase 2/3 study in US
Jan 10, 2023
States reports vaccines shortage with increased immunisation amid BF.7 scare
Dec 29, 2022
Biological E, Bharat Biotech together sitting on stockpile of 250 million COVID vaccine doses
Dec 28, 2022
Serum Institute seeks drug regulator's approval for market authorisation of its Covid vaccine as booster dose
Dec 22, 2022
Govt rubbishes reports on approval for Covaxin due to political pressure
Nov 17, 2022
CIC issues show-cause notice to CDSCO for denial of info on WHO's suspension on Covaxin procurement
Sep 13, 2022
People who took Sputnik V vaccine are in dilemma over booster dose
Aug 30, 2022
Govt nod to Corbevax as precaution dose for adults vaccinated with Covaxin, Covishield
Aug 10, 2022
Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield
Covaxin's booster dose proven to work against emerging variants: Bharat Biotech
Jul 21, 2022
Peer Reviewed : Covaxin demonstrates robust safety and immunogenicity in children 2-18 years
Jun 17, 2022
NTAGI to review Covaxin, Corbevax data for 6-12 years Thursday, discuss reducing booster dose gap
Jun 15, 2022
Covaxin booster shot enhances efficacy against Delta, Omicron variants of COVID-19: Study
Covaxin booster dose enhances vaccine effectiveness against Delta, Omicron variants: ICMR
Germany to recognize Covaxin for travel from June 1
May 27, 2022
NTAGI meeting over vaccine for children remains inconclusive
May 4, 2022
Bharat Biotech seeks DCGI nod for phase 2/3 Covaxin booster trial among 2 to 18-year-old
Delhi govt says free precaution doses at its hospitals soon
Apr 15, 2022
Copyright © 2024 Ushodaya Enterprises Pvt. Ltd., All Rights Reserved.